This bulletin presents data on drug-related hospital separations in Australia from 1993-2014 for the following drug types: opioids, cocaine, amphetamines and cannabis (NDARC)
Archives for May 2016
Bibliography: All Publications
An Evaluation of Data from Drivers Arrested for Driving Under the Influence in Relation to Per se Limits for Cannabis
Cannabis is in the spotlight in the United States due to increased levels of acceptance of its use for medical treatment, and for recreational use. Increasingly, states are proposing changes to their laws through legislative action or voter initiative to decriminalize and legalize its use. One of the major concerns shared by both opponents and proponents of greater access to cannabis ( Foundation for Traffic Safety)
‘Legal high’ usage soars as ban implementation date announced
The number of people using new psychoactive substances (NPS) in England has surged over the last few years, new data has revealed – just weeks before a ban on the drugs is due to come into effect (Police Professional)
Reviewing the indicators in the Public Health Outcome Framework
See section 5 (Parliament UK)
Landmark law to tackle legal highs commences later this month
The UK will be the first country in the world to put in place a rigorous system of testing to demonstrate that a substance is capable of having a psychoactive effect, providing evidence to support civil action and prosecutions (Home Office)
Recent changes in Europe’s MDMA/ecstasy market
This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’s MDMA market is now in a period of consolidation, there are some temporal ripple effects as latecomer countries catch up (EMCDDA)